secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0000950170-23-024071
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Spruce Biosciences director Dina Chaya resigns; Percival Barretto-Ko appointed to board
--------------------------------------------------------------------------------

- Dina Chaya, Ph.D., C.F.A. resigns from board and committees effective May 25, 2023; not due to any dispute.
- Daniel Spiegelman appointed to Nominating Committee; Kirk Ways, M.D., Ph.D. named Chair of Nominating Committee.
- Percival Barretto-Ko appointed as Class II director (term to 2025 annual meeting) and to Audit Committee.
- Barretto-Ko receives option to purchase 60,000 shares vesting over 3 years, plus annual retainers of $40,000 (director) and $7,500 (audit).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000095017023024071/0000950170-23-024071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000095017023024071/sprb-20230522.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-024071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer